Skip to content

Aortic Valve Replacement for Moderate Aortic Stenosis With Left Ventricular Decompensation Early Feasibility Study

Aortic Valve Replacement for Moderate Aortic Stenosis With Left Ventricular Decompensation Early Feasibility Study

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07060183
Enrollment
0
Registered
2025-07-11
Start date
2027-01-31
Completion date
2029-02-28
Last updated
2025-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moderate Aortic Valve Stenosis

Keywords

aortic, stenosis, valve, decompensation, moderate

Brief summary

Obtain safety and effectiveness data to support expansion for aortic valve replacement to include patients with moderate aortic stenosis and left ventricular decompensation.

Detailed description

Single-center prospective study. Subjects with moderate aortic stenosis and left ventricular decompensation will receive aortic valve replacement by the Ross procedure.

Interventions

aortic valve replacement

Sponsors

Dermed Diagnostics, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
55 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

* Moderate aortic stenosis, defined by transthoracic echocardiograph * Max aortic velocity less than 4.0 m/sec. * Mean aortic gradient less than 40.0 mmHg. * 1.0 cm2 \< Aortic Valve Area \< 1.5 cm2. * Left ventricular decompensation

Exclusion criteria

* Not suitable for the Ross procedure. * Documented history of cardiac amyloidosis.

Design outcomes

Primary

MeasureTime frameDescription
Composite rates of all-cause mortality or morbidity12 monthsComposite rate of all-cause mortality, all-stroke, life threatening or fatal bleeding, acute kidney injury, hospitalization due to procedure-related complication, or valve dysfunction requiring reintervention.

Secondary

MeasureTime frameDescription
Left ventricular compensation12 monthsImprovement in left ventricular function from baseline

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026